Developer docs
API playgroundTry for free, no card

Search company profiles

Medico Intercontinental Limited

Full company profile

uuid003kmkg

Namestring
Medico Intercontinental Limited
Legal namestring
Medico Intercontinental Limited
Company typeenum
Public
Founded yearint
1984
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, generic formulations, Vitamin D3 production, third-party manufacturing, franchise distribution
Industry3 codes
1Specialty Care Pharmaceuticals
CodeHLAIAAABPrimaryYes
2Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules)
CodeIMALAIAAPrimaryNo
3Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements)
CodeAFAFAFAJPrimaryNo
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Manufacturing
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of manufactured pharmaceutical products across multiple therapeutic categories including Gastro, Uro, Nutrition, Cosmetology, Health Devices, and Hospital segments. Products are distributed through franchise networks and direct B2B sales to healthcare providers.

medicointercontinental.com
2Third Party / Contract Manufacturing
TypeProfessional Services
Description

The company offers third-party manufacturing services to other pharmaceutical companies, providing manufacturing capacity and expertise to partners seeking production capabilities.

medicointercontinental.com
3Franchise Network Revenue
TypeLicensing Royalties
Description

Revenue generated through franchise partnerships for product distribution across geographic regions.

medicointercontinental.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Pharmaceutical products sold through franchise network
ModelOtherBilling cadenceMulti-year contract
Notes

Products are distributed through franchise partnerships with pricing determined on a quote basis through direct business inquiries. No public pricing list available.

medicointercontinental.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Calborn
Description

Vitamin D3 brand specializing in manufacturing Vitamin D3 in various grades, strengths, and forms including pharmaceutical, nutraceutical, food, and feed grade for multiple applications.

medicointercontinental.com
Core offering1 text field

Medico Intercontinental Limited manufactures and distributes a comprehensive portfolio of pharmaceutical formulations across multiple therapeutic categories (Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, Psychiatric, Derma, Eye Care) in multiple formats including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, soaps, dental, and Ayurvedic preparations. The company also operates a specialized Vitamin D3 (Cholecalciferol) brand called Calborn, a MEDICO FTF consumer product line (hand sanitizers, masks, cleaners), and offers third-party/contract manufacturing services to other pharmaceutical companies. Products are sold through direct B2B sales to healthcare providers and a franchise distribution network.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medico Intercontinental Limited is a biopharmaceutical company that manufactures and distributes a comprehensive portfolio of pharmaceutical products across multiple therapeutic categories. The company's offerings are organized into distinct product lines: General Range (the largest portfolio with tablets, capsules, soft gelatines, injectables, liquids, ointments, powders, dental, ayurvedics, soaps, nutritional, infusion, and dry syrups), Vitamin D3 (cholecalciferol in pharmaceutical, nutraceutical, food, and feed grades), MEDICO FTF (first-to-market consumer health products), Derma Range (dermatological formulations in tablets, ointments, injectables, soaps), Psychiatric Range (neuropsychiatric medications), Eye Drops (ophthalmic preparations), and Upcoming Products (pipeline formulations). The company serves global markets through research-based biopharmaceutical partnerships, focusing on making novel therapies accessible and affordable worldwide.

Product and service21 records
1Calborn Vitamin D3 (Cholecalciferol)
CategoryVitamin D3 Manufacturing
Description

Branded Vitamin D3 (Cholecalciferol) line offered in pharmaceutical, nutraceutical, food, and feed grades in oil and powder forms, for applications including bone health, immunity, calcium absorption, tablets, capsules, syrups, soft gel, sachets, shots, injections, dietary supplements, beverages, dairy products, cereals, juices, and animal nutrition.

2General Range Tablets
CategoryPharmaceutical Tablets
Description

Over 130 tablet formulations covering antibiotics (FIMI, CEFUACT, MOXIPLUS), analgesics (ACIFACT, DOLOFACT), gastrointestinal (RABICARE, OMCARE), psychiatric (GABAFACT, FLOCITOP), and other therapeutic categories for healthcare provider distribution.

3Soft Gelatin Capsules
CategoryPharmaceutical Capsules
Description

Soft gelatin capsule formulations including ALFACARE M CAP, CALCEETROL, CALCEE-K2, EFACT 400, FOLICARE PLUS, ISOFACT, LYCOFACT, MYOFACT-L, OME 369, OXYVITAL, PRIME 4G, PRIME 9G, PREGOFACT, Q CARE FORTE, and ZED-Q sold to healthcare providers.

4Hard Capsules
CategoryPharmaceutical Capsules
Description

Hard capsule formulations including BROFACT-A (acebrophylline), CINFAST-R, ESOMED-L, GLUFACT (probiotics), IT-CARE (itraconazole), IROVIT CAP, LYMARIN CAP, MOXIPLUS, OMCARE, OXYVIT, PCARE, and PREGAFACT.

5Dental Products
CategoryPharmaceutical Topicals
Description

Oral care products including ORODENT gum paint, OROFACT mouthwash, OROFACT toothpaste, and OROFACT mouth ulcer gel for dental and oral health applications.

6Ointments and Creams (General)
CategoryPharmaceutical Topicals
Description

Topical formulations including CLOFACT, CLOFACT-S, CLOFACT-PLUS, CLOFACT GM, E-FACT products, FUSIDEC, KTZ shampoo, KTMED, LULISER, MUFACT, M-FACT, RELIDERM, RELIDINE-S, RELIFEN PLUS, SERTAMED, TERBACT, and combination formulations.

7Powders and Sprays
CategoryPharmaceutical Powders and Sprays
Description

Powder and spray formulations including ARGIFACT (L-arginine), ARGIFACT DHA, CLIANCIACT powder, EMTRAL salts, GLUFACT probiotic sachets, GET D3, PROCARE powder, RELIEVE CZ, RACIMAX, and VOLIREX spray.

8Liquids and Syrups
CategoryPharmaceutical Liquids
Description

Liquid preparations including BECOFACT-L syrup, BROFACT formulations, COLD RELIEVE syrup, CODINEX, CYPROFACT, FERROFACT, GET-D3 oral solution, IROFACT SF, IROVIT, LYMARIN syrup, LIVFACT-XL, MEDISER, MEDIZINC, MKOOL, OMCARE gel, OXYVIT, OXYFACT-M, PROCARE tonic, RELIDRYL, SURFACT, TUXOL, and ZEDCARE.

9Ayurvedic Formulations
CategoryAyurvedic Pharmaceuticals
Description

Ayurvedic preparations including FEMYACT uterine tonic, LIVOFACT liver tonic, RELIEVE cough syrup, RELIFEN P oil, ULTRATONE, and ZYMIX enzyme tonic.

10Injectables
CategoryPharmaceutical Injectables
Description

Parenteral products including ALFACARE PLUS, AMIFACT (amikacin), ARSUFACT (artesunate), ARTIFACT (arteether), CEFTACT, DECOFACT (nandrolone), ESOFACT, FLOCITAM INJ, LEVOSIDE INJ, MEDICORT, MEDOL, MEROFACT, MOXIPLUS CV, ONCARE, PCARE IV, PIXIACT, RELIFEN-AQ, RANIFACT-O, RABICARE INJ, SAFECARE series, SAFEZONE-S, and TAZOMED-P.

11Dry Syrups, Suspensions and Drops
CategoryPharmaceutical Suspensions
Description

Pediatric and oral suspension formulations including ALBECTIN SUS, ACIFACT P SUS, BECOFACT drops, COLIFACT, DEFZACT SUS, FIMI dry syrup, IMMUMED SUS, KUFFACT-P, LEVEREST syrups, MEFACT P, MOXI PLUS CV DS, MOXIFORTE, ONCARE solution, OFCARE formulations, PRODOM dry syrups, RELIBEN, and ZIFT suspensions.

12Infusion Products
CategoryPharmaceutical Infusions
Description

IV infusion products including PARACT IV (paracetamol), LINZO INF (linezolid), and MANIFACT I.V (mannitol/glycerin).

13Medicated Soap Products
CategoryMedicated Personal Care
Description

Medicated soaps including PERMACT (permethrin/neem), EFACT (aloe vera/vit E), OROFACT (chlorhexidine), and KTZ (ketoconazole).

14Nutritional Products
CategoryNutritional Supplements
Description

Nutritional supplements including CAMBOGIA (garcinia weight loss) and WHEY PROTEIN POWDER.

15Eye Drops
CategoryOphthalmic Pharmaceuticals
Description

Ophthalmic formulations including CIPACT, I-NORM nasal drops, LUBRIACT, M CLOR-DX, M CLOR-CB, MCM tear drops, MDAS, MDAS-DX, MEDIFLOX, MEDIFLOX KT, OFCARE eye drops, OLOFACT, and TIMOCARE.

16Psychiatric Range Formulations
CategoryPsychiatric Pharmaceuticals
Description

Psychiatric and neurological medications including AMISURE, DIVACT-ER, EPSOMED, FLOCITAM, FLOCITOP, FLOCLID, FLOHEX, FLOBAM, FLONA, FLOPAM, FLORANZ, FLORES, FLOSERT, FLOTIN, FLOZINE, FLUXIP, GABAFACT, LEVOSIDE, MEDITRYP, OXCAR SR, PROFLO, PREGAFACT, QUP, VALFACT CR, XETA, XZOLAM, and ZOLCARE.

17Derma Range Tablets
CategoryDermatological Pharmaceuticals
Description

Dermatological tablet formulations including ALFAGLOW (glutathione complex), CLAMED-250, DOXYCARE-L, DEFZACT, FEXOFACT-120, HIZEN, KTZ-200, LEVEREST-10, TERBACT, and ZIFTMED (azithromycin).

18Derma Range Ointments and Creams
CategoryDermatological Pharmaceuticals
Description

Dermatological topical products including ALFAGLOW, CLIANCIACT (clindamycin/nicotinamide), CLOFACT-S, CLOFACT-PLUS, CALAMED lotion, E-FACT products, FUSIDEC, IT-CARE, KTMED, KTZ shampoo, LULISER, M-FACT, M-FACT HT, MUFACT, OM-TC, RELIDINE-S, SERTAMED, TACMED, and TERBACT variants.

19MEDICO FTF (First-to-Find) Consumer Products
CategoryConsumer Health Products
Description

First-to-market consumer health products including Antiseptic Liquid, Multi Purpose Cleaner, Hand Sanitizer (gel and liquid in various sizes), Hand Wash (lemon, neem/tulsi), Immunity Booster tablets, and N95 Face Masks.

20Third-Party / Contract Manufacturing Services
CategoryContract Manufacturing Services
Description

Contract manufacturing services offered to other pharmaceutical companies across multiple dosage forms including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, and Ayurvedic formulations.

21Pharmaceutical Franchise Distribution Network
CategoryPharmaceutical Distribution
Description

Franchise partner program for distribution of Medico pharmaceutical products across geographic regions in India, with dedicated franchise contact channels.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthers
Description

Medico Intercontinental provides a platform to all research-based biopharmaceutical companies, enabling them to reach their novel and innovative therapies to every part of the globe. The company is open for high-value partnerships with companies and organizations whose strength compliments and augments their own.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

The company distributes pharmaceutical products through franchise partners across geographic regions. Franchise inquiries are handled through dedicated contact channels (+91-9898508903).

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

The company offers third-party manufacturing services to other pharmaceutical companies seeking manufacturing capacity. Contact: +91-9898508911.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Larger Indian pharma with strong branded generics and OTC presence across gastro, derma, and vitamins. Comparable branded-generic orientation and therapeutic overlap, but operates at materially larger scale with deeper distribution.

TypeDirect peer
Description

Indian pharmaceutical manufacturer producing formulations across multiple dosage forms and therapeutic categories, with similar export and domestic B2B orientation. Comparable in portfolio breadth and manufacturing capability.

TypeDirect peer
Description

Indian pharma manufacturer with branded generics across multiple therapeutic areas plus API manufacturing. Similar size class, listed entity, and diversified dosage form production.

TypeDirect peer
Description

Indian specialty pharma focused on chronic therapy categories (cardio, diabetes, CNS, derma) with a similar field force and franchise distribution approach. Comparable therapeutic focus on chronic and specialty segments.

TypeDirect peer
Description

Indian specialty pharma with a comparable branded generics portfolio across multiple therapeutic areas (cardio, dermatology, ophthalmology) and similar B2B + franchise distribution model. Similar size class and product breadth make it the closest direct comparable.

TypeBroad incumbent
Description

Larger established Indian pharma with branded generics across therapeutic areas overlapping with Medico's portfolio. Comparable therapeutic categories but at significantly larger scale with deeper field force.

TypeDirect peer
Description

Indian generics manufacturer with branded formulations across multiple therapeutic segments including gastro, cardio, and dermatology. Comparable formulation-led, multi-category approach.

TypeDirect peer
Description

Smaller Indian pharma with formulation manufacturing across multiple dosage forms and OTC presence. Comparable size, similar generic formulation focus, and US export orientation.

TypeDirect peer
Description

Indian pharma with semi-regulated and regulated market focus, plus franchise distribution model for domestic business. Similar therapeutic breadth and franchise-heavy GTM.

TypeDirect peer
Description

Indian pharma with a diverse portfolio across multiple therapeutic categories including derma, gastro, and vitamins. Similar mid-tier positioning with both domestic and export sales.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medico Intercontinental Limited

Pharmaceutical Manufacturingmedicointercontinental.com

Medico Intercontinental Limited firmographics

Firmographics
Name
Medico Intercontinental Limited
Legal name
Medico Intercontinental Limited
Website
https://medicointercontinental.com
Company type
Public
Founded year
1984
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Medico Intercontinental Limited industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Specialty Care Pharmaceuticals (HLAIAAAB)
akta.pro secondary industries
Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements) (AFAFAFAJ)

Keywords

  • Pharmaceutical manufacturing
  • Generic formulations
  • Vitamin D3 production
  • Third-party manufacturing
  • Franchise distribution

Where Medico Intercontinental Limited is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Medico Intercontinental Limited business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Sale of manufactured pharmaceutical products across multiple therapeutic categories including Gastro, Uro, Nutrition, Cosmetology, Health Devices, and Hospital segments. Products are distributed through franchise networks and direct B2B sales to healthcare providers.
  2. Third Party / Contract Manufacturing: The company offers third-party manufacturing services to other pharmaceutical companies, providing manufacturing capacity and expertise to partners seeking production capabilities.
  3. Franchise Network Revenue: Revenue generated through franchise partnerships for product distribution across geographic regions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPharmaceutical products sold through franchise network

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Medico Intercontinental Limited product offering

Product offering

Core offering

Medico Intercontinental Limited manufactures and distributes a comprehensive portfolio of pharmaceutical formulations across multiple therapeutic categories (Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, Psychiatric, Derma, Eye Care) in multiple formats including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, soaps, dental, and Ayurvedic preparations. The company also operates a specialized Vitamin D3 (Cholecalciferol) brand called Calborn, a MEDICO FTF consumer product line (hand sanitizers, masks, cleaners), and offers third-party/contract manufacturing services to other pharmaceutical companies. Products are sold through direct B2B sales to healthcare providers and a franchise distribution network.

Product overview

Medico Intercontinental Limited is a biopharmaceutical company that manufactures and distributes a comprehensive portfolio of pharmaceutical products across multiple therapeutic categories. The company's offerings are organized into distinct product lines: General Range (the largest portfolio with tablets, capsules, soft gelatines, injectables, liquids, ointments, powders, dental, ayurvedics, soaps, nutritional, infusion, and dry syrups), Vitamin D3 (cholecalciferol in pharmaceutical, nutraceutical, food, and feed grades), MEDICO FTF (first-to-market consumer health products), Derma Range (dermatological formulations in tablets, ointments, injectables, soaps), Psychiatric Range (neuropsychiatric medications), Eye Drops (ophthalmic preparations), and Upcoming Products (pipeline formulations). The company serves global markets through research-based biopharmaceutical partnerships, focusing on making novel therapies accessible and affordable worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • Calborn: Vitamin D3 brand specializing in manufacturing Vitamin D3 in various grades, strengths, and forms including pharmaceutical, nutraceutical, food, and feed grade for multiple applications.

Products and services

  • Calborn Vitamin D3 (Cholecalciferol) Branded Vitamin D3 (Cholecalciferol) line offered in pharmaceutical, nutraceutical, food, and feed grades in oil and powder forms, for applications including bone health, immunity, calcium absorption, tablets, capsules, syrups, soft gel, sachets, shots, injections, dietary supplements, beverages, dairy products, cereals, juices, and animal nutrition.
  • General Range Tablets Over 130 tablet formulations covering antibiotics (FIMI, CEFUACT, MOXIPLUS), analgesics (ACIFACT, DOLOFACT), gastrointestinal (RABICARE, OMCARE), psychiatric (GABAFACT, FLOCITOP), and other therapeutic categories for healthcare provider distribution.
  • Soft Gelatin Capsules Soft gelatin capsule formulations including ALFACARE M CAP, CALCEETROL, CALCEE-K2, EFACT 400, FOLICARE PLUS, ISOFACT, LYCOFACT, MYOFACT-L, OME 369, OXYVITAL, PRIME 4G, PRIME 9G, PREGOFACT, Q CARE FORTE, and ZED-Q sold to healthcare providers.
  • Hard Capsules Hard capsule formulations including BROFACT-A (acebrophylline), CINFAST-R, ESOMED-L, GLUFACT (probiotics), IT-CARE (itraconazole), IROVIT CAP, LYMARIN CAP, MOXIPLUS, OMCARE, OXYVIT, PCARE, and PREGAFACT.
  • Dental Products Oral care products including ORODENT gum paint, OROFACT mouthwash, OROFACT toothpaste, and OROFACT mouth ulcer gel for dental and oral health applications.
  • Ointments and Creams (General) Topical formulations including CLOFACT, CLOFACT-S, CLOFACT-PLUS, CLOFACT GM, E-FACT products, FUSIDEC, KTZ shampoo, KTMED, LULISER, MUFACT, M-FACT, RELIDERM, RELIDINE-S, RELIFEN PLUS, SERTAMED, TERBACT, and combination formulations.
  • Powders and Sprays Powder and spray formulations including ARGIFACT (L-arginine), ARGIFACT DHA, CLIANCIACT powder, EMTRAL salts, GLUFACT probiotic sachets, GET D3, PROCARE powder, RELIEVE CZ, RACIMAX, and VOLIREX spray.
  • Liquids and Syrups Liquid preparations including BECOFACT-L syrup, BROFACT formulations, COLD RELIEVE syrup, CODINEX, CYPROFACT, FERROFACT, GET-D3 oral solution, IROFACT SF, IROVIT, LYMARIN syrup, LIVFACT-XL, MEDISER, MEDIZINC, MKOOL, OMCARE gel, OXYVIT, OXYFACT-M, PROCARE tonic, RELIDRYL, SURFACT, TUXOL, and ZEDCARE.
  • Ayurvedic Formulations Ayurvedic preparations including FEMYACT uterine tonic, LIVOFACT liver tonic, RELIEVE cough syrup, RELIFEN P oil, ULTRATONE, and ZYMIX enzyme tonic.
  • Injectables Parenteral products including ALFACARE PLUS, AMIFACT (amikacin), ARSUFACT (artesunate), ARTIFACT (arteether), CEFTACT, DECOFACT (nandrolone), ESOFACT, FLOCITAM INJ, LEVOSIDE INJ, MEDICORT, MEDOL, MEROFACT, MOXIPLUS CV, ONCARE, PCARE IV, PIXIACT, RELIFEN-AQ, RANIFACT-O, RABICARE INJ, SAFECARE series, SAFEZONE-S, and TAZOMED-P.
  • Dry Syrups, Suspensions and Drops Pediatric and oral suspension formulations including ALBECTIN SUS, ACIFACT P SUS, BECOFACT drops, COLIFACT, DEFZACT SUS, FIMI dry syrup, IMMUMED SUS, KUFFACT-P, LEVEREST syrups, MEFACT P, MOXI PLUS CV DS, MOXIFORTE, ONCARE solution, OFCARE formulations, PRODOM dry syrups, RELIBEN, and ZIFT suspensions.
  • Infusion Products IV infusion products including PARACT IV (paracetamol), LINZO INF (linezolid), and MANIFACT I.V (mannitol/glycerin).
  • Medicated Soap Products Medicated soaps including PERMACT (permethrin/neem), EFACT (aloe vera/vit E), OROFACT (chlorhexidine), and KTZ (ketoconazole).
  • Nutritional Products Nutritional supplements including CAMBOGIA (garcinia weight loss) and WHEY PROTEIN POWDER.
  • Eye Drops Ophthalmic formulations including CIPACT, I-NORM nasal drops, LUBRIACT, M CLOR-DX, M CLOR-CB, MCM tear drops, MDAS, MDAS-DX, MEDIFLOX, MEDIFLOX KT, OFCARE eye drops, OLOFACT, and TIMOCARE.
  • Psychiatric Range Formulations Psychiatric and neurological medications including AMISURE, DIVACT-ER, EPSOMED, FLOCITAM, FLOCITOP, FLOCLID, FLOHEX, FLOBAM, FLONA, FLOPAM, FLORANZ, FLORES, FLOSERT, FLOTIN, FLOZINE, FLUXIP, GABAFACT, LEVOSIDE, MEDITRYP, OXCAR SR, PROFLO, PREGAFACT, QUP, VALFACT CR, XETA, XZOLAM, and ZOLCARE.
  • Derma Range Tablets Dermatological tablet formulations including ALFAGLOW (glutathione complex), CLAMED-250, DOXYCARE-L, DEFZACT, FEXOFACT-120, HIZEN, KTZ-200, LEVEREST-10, TERBACT, and ZIFTMED (azithromycin).
  • Derma Range Ointments and Creams Dermatological topical products including ALFAGLOW, CLIANCIACT (clindamycin/nicotinamide), CLOFACT-S, CLOFACT-PLUS, CALAMED lotion, E-FACT products, FUSIDEC, IT-CARE, KTMED, KTZ shampoo, LULISER, M-FACT, M-FACT HT, MUFACT, OM-TC, RELIDINE-S, SERTAMED, TACMED, and TERBACT variants.
  • MEDICO FTF (First-to-Find) Consumer Products First-to-market consumer health products including Antiseptic Liquid, Multi Purpose Cleaner, Hand Sanitizer (gel and liquid in various sizes), Hand Wash (lemon, neem/tulsi), Immunity Booster tablets, and N95 Face Masks.
  • Third-Party / Contract Manufacturing Services Contract manufacturing services offered to other pharmaceutical companies across multiple dosage forms including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, and Ayurvedic formulations.
  • Pharmaceutical Franchise Distribution Network Franchise partner program for distribution of Medico pharmaceutical products across geographic regions in India, with dedicated franchise contact channels.

Companies that use Medico Intercontinental Limited

Customer profile

Segments4 records

Ideal customer profiles4 records

Medico Intercontinental Limited technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Medico Intercontinental Limited partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Research-based Biopharmaceutical CompaniescoreOthersMedico Intercontinental provides a platform to all research-based biopharmaceutical companies, enabling them to reach their novel and innovative therapies to every part of the globe. The company is open for high-value partnerships with companies and organizations whose strength compliments and augments their own.
  • Franchise PartnerscoreChannel Partner/ Reseller/ DistributorThe company distributes pharmaceutical products through franchise partners across geographic regions. Franchise inquiries are handled through dedicated contact channels (+91-9898508903).
  • Third-party Manufacturing ClientsminorChannel Partner/ Reseller/ DistributorThe company offers third-party manufacturing services to other pharmaceutical companies seeking manufacturing capacity. Contact: +91-9898508911.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Medico Intercontinental Limited competitors and assessment

Company assessment

Broad incumbents

  • Mankind Pharma Limited: Larger Indian pharma with strong branded generics and OTC presence across gastro, derma, and vitamins. Comparable branded-generic orientation and therapeutic overlap, but operates at materially larger scale with deeper distribution.
  • Torrent Pharmaceuticals Limited: Larger established Indian pharma with branded generics across therapeutic areas overlapping with Medico's portfolio. Comparable therapeutic categories but at significantly larger scale with deeper field force.

Direct peers

  • Ipca Laboratories Limited: Indian pharmaceutical manufacturer producing formulations across multiple dosage forms and therapeutic categories, with similar export and domestic B2B orientation. Comparable in portfolio breadth and manufacturing capability.
  • Alembic Pharmaceuticals Limited: Indian pharma manufacturer with branded generics across multiple therapeutic areas plus API manufacturing. Similar size class, listed entity, and diversified dosage form production.
  • Eris Lifesciences Limited: Indian specialty pharma focused on chronic therapy categories (cardio, diabetes, CNS, derma) with a similar field force and franchise distribution approach. Comparable therapeutic focus on chronic and specialty segments.
  • Ajanta Pharma Limited: Indian specialty pharma with a comparable branded generics portfolio across multiple therapeutic areas (cardio, dermatology, ophthalmology) and similar B2B + franchise distribution model. Similar size class and product breadth make it the closest direct comparable.
  • Unichem Laboratories Limited: Indian generics manufacturer with branded formulations across multiple therapeutic segments including gastro, cardio, and dermatology. Comparable formulation-led, multi-category approach.
  • Marksans Pharma Limited: Smaller Indian pharma with formulation manufacturing across multiple dosage forms and OTC presence. Comparable size, similar generic formulation focus, and US export orientation.
  • Caplin Point Laboratories Limited: Indian pharma with semi-regulated and regulated market focus, plus franchise distribution model for domestic business. Similar therapeutic breadth and franchise-heavy GTM.
  • JB Chemicals & Pharmaceuticals Limited: Indian pharma with a diverse portfolio across multiple therapeutic categories including derma, gastro, and vitamins. Similar mid-tier positioning with both domestic and export sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights5 records

Customer concentration

Medico Intercontinental Limited financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medico Intercontinental Limited leadership team

Management profile

Number of profiles

Profiles6 records

Medico Intercontinental Limited subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Medico Intercontinental Limited funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medico Intercontinental Limited M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medico Intercontinental Limited

What does Medico Intercontinental Limited do?

Medico Intercontinental Limited manufactures and distributes a comprehensive portfolio of pharmaceutical formulations across multiple therapeutic categories (Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital, Psychiatric, Derma, Eye Care) in multiple formats including tablets, capsules, soft gelatin capsules, injectables, ointments, liquids, dry syrups, suspensions, infusions, soaps, dental, and Ayurvedic preparations. The company also operates a specialized Vitamin D3 (Cholecalciferol) brand called Calborn, a MEDICO FTF consumer product line (hand sanitizers, masks, cleaners), and offers third-party/contract manufacturing services to other pharmaceutical companies. Products are sold through direct B2B sales to healthcare providers and a franchise distribution network.

Is Medico Intercontinental Limited a public or private company?

Medico Intercontinental Limited is a public company. It is classified as public and is currently operating.

When was Medico Intercontinental Limited founded?

Medico Intercontinental Limited was founded in 1984. It employs 11 to 50 people.

Where is Medico Intercontinental Limited based?

Medico Intercontinental Limited is headquartered in Ahmedabad, India, in the Asia region.

How does Medico Intercontinental Limited make money?

Three revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are third Party / Contract Manufacturing and franchise Network Revenue.

Who are Medico Intercontinental Limited's main competitors?

Broad incumbents on record are Mankind Pharma Limited and Torrent Pharmaceuticals Limited. Direct peers are Ipca Laboratories Limited, Alembic Pharmaceuticals Limited, Eris Lifesciences Limited, Ajanta Pharma Limited, Unichem Laboratories Limited, Marksans Pharma Limited, Caplin Point Laboratories Limited and JB Chemicals & Pharmaceuticals Limited.

Does Medico Intercontinental Limited have an API?

No public API is recorded for Medico Intercontinental Limited.

What industry is Medico Intercontinental Limited in?

Medico Intercontinental Limited's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals